These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 6312747)

  • 1. Evidence for interactions between striatal cholecystokinin and glutamate receptors. CCK-8 in vitro produces a marked downregulation of 3H-glutamate binding sites in striatal membranes.
    Fuxe K; Agnati LF; Celani MF
    Acta Physiol Scand; 1983 May; 118(1):75-7. PubMed ID: 6312747
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
    Fuxe K; Agnati LF; Benfenati F; Celani M; Zini I; Zoli M; Mutt V
    J Neural Transm Suppl; 1983; 18():165-79. PubMed ID: 6192208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites.
    Agnati LF; Celani MF; Fuxe K
    Acta Physiol Scand; 1983 May; 118(1):79-81. PubMed ID: 6312748
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes.
    Agnati LF; Fuxe K; Battistini N; Benfenati F
    Acta Physiol Scand; 1984 Mar; 120(3):465-7. PubMed ID: 6331074
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites.
    Fuxe K; Agnati LF; Benfenati F; Cimmino M; Algeri S; Hökfelt T; Mutt V
    Acta Physiol Scand; 1981 Dec; 113(4):567-9. PubMed ID: 6291324
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
    Chang RS; Lotti VJ; Chen TB; Kunkel KA
    Mol Pharmacol; 1986 Sep; 30(3):212-7. PubMed ID: 3018478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of [3H]-dopamine binding by cholecystokinin octapeptide (CCK-8).
    Murphy RB; Schuster DI
    Peptides; 1982; 3(3):539-43. PubMed ID: 6289286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased binding of [3H]GABA to striatal membranes following ischemia.
    Francis A; Pulsinelli W
    J Neurochem; 1983 May; 40(5):1497-9. PubMed ID: 6300337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
    J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.
    Makovec F; Bani M; Chisté R; Revel L; Rovati LC; Rovati LA
    Arzneimittelforschung; 1986; 36(1):98-102. PubMed ID: 3006713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin in the central nervous system.
    Beinfeld MC; Meyer DK; Brownstein MJ
    Peptides; 1981; 2 Suppl 2():77-9. PubMed ID: 6283500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Bruns RF; Lu GH; Pugsley TA
    Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
    Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J
    Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cholecystokinin receptors on rat pancreatic membranes.
    Steigerwalt RW; Williams JA
    Endocrinology; 1981 Nov; 109(5):1746-53. PubMed ID: 6271541
    [No Abstract]   [Full Text] [Related]  

  • 18. Tritium-sensitive film autoradiography of [3H]cholecystokinin-5/pentagastrin receptors in rat brain.
    Gaudreau P; Quirion R; St-Pierre S; Pert CB
    Eur J Pharmacol; 1983 Jan; 87(1):173-4. PubMed ID: 6301853
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased [3H]glutamate receptor binding in aged rats.
    Baudry M; Arst DS; Lynch G
    Brain Res; 1981 Oct; 223(1):195-8. PubMed ID: 6269700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCK-nitric oxide interaction in rat cortex, striatum and pallidum.
    Ferraro G; Sardo P; Di Giovanni G; Di Maio R; La Grutta V
    Comp Biochem Physiol C Toxicol Pharmacol; 2003 Aug; 135(4):425-33. PubMed ID: 12965187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.